T-Cell Vaccination: An Insight Into T-Cell Regulation

I. R. Cohen; N. Friedman; F. J. Quintana

doi:10.1016/B978-0-12-801914-6.00031-3

T-Cell Vaccination: An Insight Into T-Cell Regulation

I. R. Cohen^*, N. Friedman, F. J. Quintana

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Here we review T-cell vaccination (TCV), a cell-based, generic approach to immune regulation. We describe TCV clinical trials in multiple sclerosis and other autoimmune diseases; we analyze the immune regulatory mechanisms activated by TCV; we examine the potential of public T cells as TCV mediators, and we discuss the physiology of immune regulation in the light of TCV.

Original language	American English
Title of host publication	Translational Neuroimmunology in Multiple Sclerosis
Subtitle of host publication	From Disease Mechanisms to Clinical Applications
Publisher	Elsevier Inc.
Pages	457-473
Number of pages	17
ISBN (Electronic)	9780128020074
ISBN (Print)	9780128019146
DOIs	https://doi.org/10.1016/B978-0-12-801914-6.00031-3
State	Published - 3 Aug 2016
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.

Keywords

Antibodies
Antiergotype
Antiidiotype
Autoimmunity
Cell therapy
T cells
T-cell vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-801914-6.00031-3

Cite this

@inbook{a038f82c5453424f87f0b9d32d5f2dd3,

title = "T-Cell Vaccination: An Insight Into T-Cell Regulation",

abstract = "Here we review T-cell vaccination (TCV), a cell-based, generic approach to immune regulation. We describe TCV clinical trials in multiple sclerosis and other autoimmune diseases; we analyze the immune regulatory mechanisms activated by TCV; we examine the potential of public T cells as TCV mediators, and we discuss the physiology of immune regulation in the light of TCV.",

keywords = "Antibodies, Antiergotype, Antiidiotype, Autoimmunity, Cell therapy, T cells, T-cell vaccination",

author = "Cohen, {I. R.} and N. Friedman and Quintana, {F. J.}",

year = "2016",

month = aug,

day = "3",

doi = "10.1016/B978-0-12-801914-6.00031-3",

language = "American English",

isbn = "9780128019146",

pages = "457--473",

booktitle = "Translational Neuroimmunology in Multiple Sclerosis",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - T-Cell Vaccination

T2 - An Insight Into T-Cell Regulation

AU - Cohen, I. R.

AU - Friedman, N.

AU - Quintana, F. J.

PY - 2016/8/3

Y1 - 2016/8/3

N2 - Here we review T-cell vaccination (TCV), a cell-based, generic approach to immune regulation. We describe TCV clinical trials in multiple sclerosis and other autoimmune diseases; we analyze the immune regulatory mechanisms activated by TCV; we examine the potential of public T cells as TCV mediators, and we discuss the physiology of immune regulation in the light of TCV.

AB - Here we review T-cell vaccination (TCV), a cell-based, generic approach to immune regulation. We describe TCV clinical trials in multiple sclerosis and other autoimmune diseases; we analyze the immune regulatory mechanisms activated by TCV; we examine the potential of public T cells as TCV mediators, and we discuss the physiology of immune regulation in the light of TCV.

KW - Antibodies

KW - Antiergotype

KW - Antiidiotype

KW - Autoimmunity

KW - Cell therapy

KW - T cells

KW - T-cell vaccination

UR - http://www.scopus.com/inward/record.url?scp=84987904215&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801914-6.00031-3

DO - 10.1016/B978-0-12-801914-6.00031-3

M3 - Chapter

AN - SCOPUS:84987904215

SN - 9780128019146

SP - 457

EP - 473

BT - Translational Neuroimmunology in Multiple Sclerosis

PB - Elsevier Inc.

ER -

T-Cell Vaccination: An Insight Into T-Cell Regulation

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this